---
figid: PMC7611899__EMS137171-f001
figtitle: Fibrosis development and signaling pathways
organisms:
- Severe acute respiratory syndrome coronavirus 2
- Hepatitis B virus
- Adenoviridae
- Severe acute respiratory syndrome-related coronavirus
- Middle East respiratory syndrome-related coronavirus
- Enterovirus
- Suid alphaherpesvirus 1
- recombinant Hepatitis B virus
- Mus musculus
- Rattus norvegicus
- Allium sativum
- Punica granatum
- Homo sapiens
- Sus scrofa
- Salmonella enterica subsp. enterica serovar Typhimurium
- NA
pmcid: PMC7611899
filename: EMS137171-f001.jpg
figlink: /pmc/articles/PMC7611899/figure/F1/
number: F1
caption: (a) The development of fibrosis begins with physiology-disturbing events
  that cause tissue damage. In response to this damage, cells secrete inflammatory
  cytokines that activate fibrogenic and immune cells. Consequently, fibrogenic and
  immune cells respond to this cascade by producing cytokines, chemokines, and growth
  factors aiming to resolve the inflammation. In some cases, the inflammation persists
  and fibroblasts are continuously activated to myofibroblasts resulting in excessive
  fibrotic tissue remodeling. (b) The release of specific signaling molecules by fibrogenic
  and immune cells initiates a cascade of interactions that eventually leads to fibrosis.
  Several signaling pathways have been incriminated for contribution to fibrosis with
  the canonical TGF-β/Smad-2/3 pathway to be the most prominent contributor. Non-canonical
  (i.e., non-Smad-2/3-dependent) pathways, such as the Wnt/β-catenin, the p38 MAPK,
  the NF-kB, and the PI3K/Akt/mTOR, further enhance fibrosis and inflammation [,,,].
papertitle: Therapeutic and diagnostic targeting of fibrosis in metabolic, proliferative
  and viral disorders.
reftext: Alexandros Marios Sofias, et al. Adv Drug Deliv Rev. ;175:113831-113831.
year: '2021'
doi: 10.1016/j.addr.2021.113831
journal_title: Advanced drug delivery reviews
journal_nlm_ta: Adv Drug Deliv Rev
publisher_name: ''
keywords: Fibrosis | drug targeting | nanomedicine | imaging | atherosclerosis | cardiovascular
  disease | cancer | diabetes | liver | viral infection
automl_pathway: 0.8948774
figid_alias: PMC7611899__F1
figtype: Figure
organisms_ner:
- Sus scrofa
- Rattus norvegicus
- Homo sapiens
- Mus musculus
redirect_from: /figures/PMC7611899__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7611899__EMS137171-f001.html
  '@type': Dataset
  description: (a) The development of fibrosis begins with physiology-disturbing events
    that cause tissue damage. In response to this damage, cells secrete inflammatory
    cytokines that activate fibrogenic and immune cells. Consequently, fibrogenic
    and immune cells respond to this cascade by producing cytokines, chemokines, and
    growth factors aiming to resolve the inflammation. In some cases, the inflammation
    persists and fibroblasts are continuously activated to myofibroblasts resulting
    in excessive fibrotic tissue remodeling. (b) The release of specific signaling
    molecules by fibrogenic and immune cells initiates a cascade of interactions that
    eventually leads to fibrosis. Several signaling pathways have been incriminated
    for contribution to fibrosis with the canonical TGF-β/Smad-2/3 pathway to be the
    most prominent contributor. Non-canonical (i.e., non-Smad-2/3-dependent) pathways,
    such as the Wnt/β-catenin, the p38 MAPK, the NF-kB, and the PI3K/Akt/mTOR, further
    enhance fibrosis and inflammation [,,,].
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SMAD7
  - SMAD2
  - SMAD3
  - SMAD4
  - TGFBR2
  - CMKLR1
  - CTNNB1
  - MMP
  - ADAM10
  - TNF
  - IL-6
  - REL
  - TLR4
  - NFKBIA
  - AKT1
  - MTOR
  - IL13
  - Smad7
  - Tgfbr1
  - Smad2
  - Smad3
  - Tgfb1
  - Smad4
  - Timp1
  - Tas2r134
  - Rxfp2
  - Ctnnb1
  - Wnt2
  - Mapk14
  - Adam10
  - Twist1
  - Tnf
  - Il6
  - Rel
  - Npc2
  - Tlr4
  - Nfkb1
  - Rela
  - Pik3cg
  - Akt1
  - Mtor
  - Il13
  - TGFBR1
  - COL6A1
  - COL6A2
  - COL6A3
  - COL6A5
  - COL6A6
  - COL7A1
  - COL8A1
  - COL8A2
  - COL9A1
  - COL9A2
  - COL9A3
  - COL10A1
  - COL11A1
  - COL11A2
  - COL12A1
  - COL13A1
  - COL14A1
  - COL15A1
  - COL16A1
  - COL17A1
  - COL18A1
  - COL19A1
  - COL20A1
  - COL21A1
  - COL22A1
  - COL23A1
  - COL24A1
  - COL25A1
  - COL26A1
  - COL27A1
  - COL28A1
  - COL1A1
  - COL1A2
  - COL4A1
  - COL4A2
  - COL4A3
  - COL4A4
  - COL4A5
  - COL4A6
  - COL5A1
  - COL5A2
  - COL5A3
  - TGFB1
  - TGFB2
  - TGFB3
  - TIMP1
  - ACTA1
  - CXCL10
  - CXCL11
  - CXCL12
  - CXCL13
  - CXCL14
  - CXCL9
  - PF4
  - CXCL1
  - CXCL2
  - CXCL3
  - CXCL5
  - CXCL6
  - CXCL8
  - PPBP
  - FZD4
  - NMUR1
  - LPAR3
  - LGR6
  - MRGPRX3
  - MRGPRX4
  - GPR151
  - OXER1
  - GPRC6A
  - MRGPRX1
  - VN1R17P
  - GPR166P
  - GRM1
  - GRM2
  - GRM3
  - GRM4
  - GRM5
  - GRM6
  - GRM7
  - GRM8
  - CASR
  - GABBR1
  - GABBR2
  - GPR156
  - GPR158
  - GPR179
  - GPRC5A
  - GPRC5B
  - GPRC5C
  - GPRC5D
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - CRK
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MMP1
  - MMP2
  - MMP3
  - MMP7
  - MMP8
  - MMP9
  - MMP10
  - MMP11
  - MMP12
  - MMP13
  - MMP14
  - MMP15
  - MMP16
  - MMP17
  - MMP19
  - MMP20
  - MMP21
  - MMP23B
  - MMP24
  - MMP25
  - MMP26
  - MMP27
  - MMP28
  - TWIST1
  - IL6
  - CD40
  - ARHGEF7
  - ASCC1
  - H3P40
  - IL1B
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - TBK1
  - NFKB1
  - RELA
  - RELB
  - NFKB2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT2
  - AKT3
  - Ltbp1
  - Acta2
  - Gpbar1
  - Crk
  - Grap2
  - Syp
  - Ahsa1
  - Cdc37
  - Lsp1
  - Pold2
  - Cd40
  - Dctn2
  - Il1
  - Pik3r1
---
